CN102600438B - Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease - Google Patents
Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease Download PDFInfo
- Publication number
- CN102600438B CN102600438B CN201210118802.3A CN201210118802A CN102600438B CN 102600438 B CN102600438 B CN 102600438B CN 201210118802 A CN201210118802 A CN 201210118802A CN 102600438 B CN102600438 B CN 102600438B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- root
- hyperlipidemia
- hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease. The medicament comprises the following components in parts by weight: 30 parts of dried rehmannia root, 10 parts of radix ophiopogonis, 20 parts of root of Chinese trichosanthes, 30 parts of root of kudzu vine, 10 parts of epimedium, 30 parts of astragalus root, 20 parts of yams, 25 parts of root of bidentate achyranthes, 15 parts of uncaria, 15 parts of sea clam shells, 10 parts of asafetida, 10 parts of pipe fish, 25 parts of polygonum multiflorum, 10 parts of parasitic loranthus, 10 parts of radix curcumae, 20 parts of root of red-rooted salvia, 10 parts of pericarpium trichosanthis, 15 parts of seed of Chinese dodder and 15 parts of Szechuan lovage rhizome.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of diabetes, hypertension, hyperlipidemia and coronary heart disease.
Background technology
Diabetes are by inherited genetic factors, immunologic function disorder, infected by microbes and toxin thereof, free radical toxin, the various virulence factors of Nervous and Mental Factors etc. act on body and cause hypoinsulinism, insulin resistant etc. and the sugar that causes, protein, fat, a series of metabolism disorder syndromes such as power and water Xie Zhi, take hyperglycemia clinically as main feature, can there is polyuria in model case, polydipsia, polyphagia, the performance such as become thin, i.e. " three-many-one-little " symptom, diabetes (blood glucose) cause complication once control bad meeting, cause kidney, eye, the exhaustion pathological changes at the positions such as foot, and cannot cure.
Hypertension (hypertensive disease) is a kind ofly to take arteriotony and continue to raise be often to cause the chronic disease of main manifestations the pathological changes of the vitals such as the heart, brain, kidney and to occur corresponding consequence.Lipid metabolism or running make one or more lipids of blood plasma higher than being normally called hyperlipidemia extremely.Hyperlipidemia is a kind of systemic disease, refers to that T-CHOL in blood (TC) and/or triglyceride (TG) are too high or HDL-C (HDL-C) is too low, and modern medicine is referred to as dyslipidemia.Lipid is insoluble or be slightly soluble in water, must with lipoprotein form, exist with protein bound, and therefore, hyperlipidemia is conventionally also referred to as hyperlipoproteinemia.The cause of disease of hyperlipidemia, can be divided into two large class, i.e. In Patients With Primary Hyperlipoidemia and Secondary cases hyperlipidemias substantially.
In Patients With Primary Hyperlipoidemia
1, inherited genetic factors.Heredity can cause hyperlipemia by number of mechanisms, some may occur on cellular level, main manifestations is the defect (as the defect of lipoprotein lipase or shortage) of some enzyme in cell surface lipoprotein receptor volume defect and cell, also can occur on the molecule of lipoprotein or apolipoprotein, how because genetic flaw causes.
2, dietary factor.Dietary factor effect more complicated, it is closely-related with dietary factor that patients with hyperlipoproteinemia has sizable ratio in being in hospital.
3, clinical experiment shows: the normocyte in blood, colloid particle etc. are electronegative, between them, mutually repels, and maintains a certain distance, and the aging erythrocyte of pathological changes is because electronics is fought for, positively charged, due to positive negative suction, that red blood cell condensation is agglomerating, cause hyperlipidemia.
Secondary cases hyperlipidemia
Secondary cases hyperlipidemia is that these diseases comprise: diabetes, hepatopathy, thyroid disease, kidney disease, pancreas, obesity, glycogen storage disease, gout, bronzed disease, Cushing's syndrome, abnormal globulin mass formed by blood stasis etc. due to primary disease institute causer in the middle of other.
1, diabetes and hyperlipoproteinemia.In human body, between carbohydrate metabolism and lipid metabolism, there is close contacting, clinical research discovery, approximately 40% diabetics can secondary cause hyperlipemia.
2, hepatopathy and hyperlipoproteinemia.Modern medicine study data confirms, many materials comprise that lipid and lipoprotein etc. processes, produces and decompose at liver, drains.Once liver has pathological changes, lipid and lipoprotein metabolism also will get muddled.
3, obesity and hyperlipoproteinemia.Local clinic study data shows, the Chang Jifa of obesity causes blood triglyceride increased content, and some patients were first cholesterolemia content also may increase, and main manifestations is iv type hyperlipoproteinemia mostly, is secondly iib type hyperlipoproteinemia.
Summary of the invention
The object of this invention is to provide a kind of medicine for the treatment of diabetes, hypertension, hyperlipidemia and coronary heart disease.
The present invention is comprised of the component of following weight parts:
30 parts of Radix Rehmanniae, 10 parts of Radix Ophiopogonis, 20 parts of Radix Trichosanthis, 30 parts of Radix Puerariaes, 15 parts of Herba Epimedii, 30 parts of Radix Astragali, 20 parts of Rhizoma Dioscoreaes, 25 parts of Radix Achyranthis Bidentataes, 15 parts of Ramulus Uncariae Cum Uncis, 15 parts of Concha Meretricis seu Cyclinaes, 10 parts of Resina Ferulaes, 10 parts of Solenognathus, 25 parts of Radix Polygoni Multiflori, 10 parts of Herba Taxillis, 10 parts of Radix Curcumaes, 20 parts of Radix Salviae Miltiorrhizaes, 10 parts of Pericarpium Trichosanthiss, 15 parts of Semen Cuscutae, 15 parts of Rhizoma Chuanxiongs.
The present invention is with Radix Rehmanniae, Radix Ophiopogonis, Radix Trichosanthis, Radix Puerariae, Herba Epimedii invigorating the spleen and replenishing QI, YIN nourishing and the production of body fluid promoting, the yang invigorating of quenching one's thirst; With Radix Astragali, Rhizoma Dioscoreae invigorating the spleen and benefiting QI; With Radix Achyranthis Bidentatae, Ramulus Uncariae Cum Uncis, Concha Meretricis seu Cyclinae, Resina Ferulae, the steady blood pressure of Solenognathus; With Radix Polygoni Multiflori, Herba Taxilli and Radix Curcumae purify the blood fat melting and thrombolytic; With the multiple arteries and veins of Radix Salviae Miltiorrhizae, Pericarpium Trichosanthis, Semen Cuscutae and Rhizoma Chuanxiong dredging collateral, kidney nourishing water, contains edema with the liver involved, and heart-fire, falls in strengthening the spleen soil, except scorching, and Ji blood.
Beneficial effect of the present invention:
The present invention has invigorating the spleen and replenishing QI, phencyclidine, moisturizes, tonifying the kidney to consolidate the essence, promoting the production of body fluid to quench thirst, eliminating phlegm to promote tissue regeneration, supplementing QI and nourishing YIN, blood circulation promoting and blood stasis dispelling, multiple arteries and veins, blood nourishing acupuncture-stimulating, invigorating the spleen and benefiting QI, clearing away heat-damp and promoting diuresis and consolidate the effect of righting nourish heart.The effect with treatment diabetes, hypertension, hyperlipidemia and coronary heart disease.
The specific embodiment
The present embodiment is comprised of the component of following weight parts:
Radix Rehmanniae 30g, Radix Ophiopogonis 10g, Radix Trichosanthis 20g, Radix Puerariae 30g, Herba Epimedii 15g, Radix Astragali 30g, Rhizoma Dioscoreae 20g, Radix Achyranthis Bidentatae 25g, Ramulus Uncariae Cum Uncis 15g, Concha Meretricis seu Cyclinae 15g, Resina Ferulae 10g, Solenognathus 10g, Radix Polygoni Multiflori 25g, Herba Taxilli 10g, Radix Curcumae 10g, Radix Salviae Miltiorrhizae 20g, Pericarpium Trichosanthis 10g, Semen Cuscutae 15g, Rhizoma Chuanxiong 15g.According to above-mentioned formula, make decoction, every milliliter contained 1g, every day 3 times, each serving 50~80ml.
Treatment diabetes case: Liu, female, 53 years old.Suffer from diabetes 3 years, one takes insoral.Empty stomach glucose in urine (+++), blood glucose 238mg/dl (13.3mmol/L), blood glucose 327mg/dl (18.2mmol/L) after food.Thirsty polydipsia, urine amount is many, the soreness of waist, spirit is tired, and large dry stool is dizzy nervous, easily perspires, very scorching, deficiency in origin and excess in superficiality.Take the present invention's medicine 35 days, thirstyly stop, glucose in urine is normal, and spirit takes a turn for the better.
Treatment hypertension, hyperlipidemia and coronary heart disease case: Zhang, man, 65 years old, suffer from hypertension, hyperlipidemia and coronary heart disease simultaneously, take Western medicine blood pressure lowering, eat less greasy food blood fat reducing, and then avoid the outbreak of coronary heart disease, take Western medicine blood pressure lowering and formed dependency.This medicine that takes the present invention is after March, and blood pressure is basicly stable within normal range, and blood fat obviously reduces, and coronary heart disease was not shown effect within 1 year.
Claims (1)
1. treat a medicine for diabetes, hypertension, hyperlipidemia and coronary heart disease, by the component of following weight parts, formed:
30 parts of Radix Rehmanniae, 10 parts of Radix Ophiopogonis, 20 parts of Radix Trichosanthis, 30 parts of Radix Puerariaes, 15 parts of Herba Epimedii, 30 parts of Radix Astragali, 20 parts of Rhizoma Dioscoreaes, 25 parts of Radix Achyranthis Bidentataes, 15 parts of Ramulus Uncariae Cum Uncis, 15 parts of Concha Meretricis seu Cyclinaes, 10 parts of Resina Ferulaes, 10 parts of Solenognathus, 25 parts of Radix Polygoni Multiflori, 10 parts of Herba Taxillis, 10 parts of Radix Curcumaes, 20 parts of Radix Salviae Miltiorrhizaes, 10 parts of Pericarpium Trichosanthiss, 15 parts of Semen Cuscutae, 15 parts of Rhizoma Chuanxiongs.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210118802.3A CN102600438B (en) | 2012-04-21 | 2012-04-21 | Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210118802.3A CN102600438B (en) | 2012-04-21 | 2012-04-21 | Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102600438A CN102600438A (en) | 2012-07-25 |
CN102600438B true CN102600438B (en) | 2014-04-23 |
Family
ID=46518457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210118802.3A Active CN102600438B (en) | 2012-04-21 | 2012-04-21 | Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102600438B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103721187A (en) * | 2013-12-20 | 2014-04-16 | 安徽金太阳生化药业有限公司 | Blood-circulation-promoting and blood-fat-reducing pill for treating hyperlipemia and preparation method of pill |
CN104547959A (en) * | 2015-02-09 | 2015-04-29 | 王士国 | Traditional Chinese medicine composition for treating hyperlipidemia and preparation method thereof |
CN104922505A (en) * | 2015-05-31 | 2015-09-23 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treating coronary heart disease stable angina pectoris complicated with hypertension and hyperlipidemia |
CN106074980A (en) * | 2016-07-29 | 2016-11-09 | 任立群 | A kind of blood fat reducing healthcare food |
CN106389777A (en) * | 2016-11-29 | 2017-02-15 | 汪承武 | Traditional Chinese medicine for treating diabetes accompanied by hyperlipidemia and preparation method |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1088450A (en) * | 1993-01-01 | 1994-06-29 | 淄博市淄川区第二制药厂 | The excellent blood fat reducing of preparation of treatment hyperlipidemia |
CN1124153C (en) * | 2001-08-31 | 2003-10-15 | 石家庄以岭药业股份有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
CN1443544A (en) * | 2002-03-07 | 2003-09-24 | 张世均 | Chinese medicine Jiangtang Tongmailing for curing diabetes and preventing and curing complicating diseases and its preparation method |
CN1202854C (en) * | 2003-04-01 | 2005-05-25 | 四川省中医药研究院中医研究所 | Chinese medicine possessing kidney supplementing brain fortifying, statis transforming and vessel freeing actions |
CN1555817A (en) * | 2003-12-30 | 2004-12-22 | 王胜霞 | Medicine ginseng and astragalus yam paste for treating diabates and its preparation method |
JP4892856B2 (en) * | 2004-04-15 | 2012-03-07 | 大正製薬株式会社 | Female hormone balance regulator |
CN1970069B (en) * | 2006-12-26 | 2010-10-06 | 曹国胜 | Chinese medicinal pill for treating coronary heart disease |
CN102178786B (en) * | 2011-05-04 | 2013-03-13 | 重庆康刻尔制药有限公司 | Medicament combination for treating diabetic peripheral neuropathy as well as preparation method and application thereof |
CN102397459A (en) * | 2011-10-19 | 2012-04-04 | 李顺光 | Traditional Chinese medicine for treating diabetes and preparation method thereof |
-
2012
- 2012-04-21 CN CN201210118802.3A patent/CN102600438B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN102600438A (en) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102600438B (en) | Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease | |
CN103040960A (en) | Traditional Chinese medicine formula for treating high blood pressure | |
CN101766783A (en) | Traditional Chinese medicine combination for treating cholecystitis and capsule preparation method thereof | |
CN103933220A (en) | Medicine for treating climacteric syndrome | |
CN102641430B (en) | Traditional Chinese medicine decoction for treating diabetic nephropathy (DN) | |
CN102178788B (en) | Chinese medicinal composition for reducing transaminase and jaundice and preparation method thereof | |
CN102526611B (en) | Chinese medicinal composition for treating chronic heart failure | |
CN101073660A (en) | Chinese-medicinal composition for treating chronic hepatitis B and its production | |
CN104013806B (en) | A kind of Chinese prescription for being used to treat diabetes | |
CN102764366B (en) | Traditional Chinese medicine for treating chronic lymphatic thyroiditis | |
CN101549045B (en) | Traditional Chinese medicine preparation for treating diabetes and preparation method thereof | |
CN103417694A (en) | Traditional Chinese medicine used for treating diabetes | |
CN103638389A (en) | Traditional Chinese medicine composition for treating diabetes | |
CN103463358A (en) | Traditional Chinese medicine compound preparation for treatment of diabetes and preparation method thereof | |
CN103566183A (en) | Medicament for treating diabetic nephropathy | |
CN104043080B (en) | Chinese medicine composition for the treatment of nephritis and preparation method thereof | |
CN103585361A (en) | Traditional Chinese medicine preparation for treating subclinical hypothroidism | |
CN103566279A (en) | Medicine for treating hypertension | |
CN104922489B (en) | A kind of Chinese medicine composition for treating chronic nephritis and preparation method thereof | |
CN102038906A (en) | Medicament for treating psoriasis | |
CN101890145B (en) | Medicament for treating diabetes and preparation thereof | |
CN101264163A (en) | Chinese medicine powder for treating headache | |
CN106421125A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
CN104415226A (en) | Liquid medicine for treating diabetes | |
CN104306700A (en) | Tongmai Decoction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210204 Address after: Room 608, unit 3, building 2, Carnival community, Luyuan District, Changchun City, Jilin Province Patentee after: Han Hexu Patentee after: Yi Gangqiao Address before: Room 608, unit 3, building 2, Carnival community, Luyuan District, Changchun City, Jilin Province Patentee before: Han Hexu |